JP2011528665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528665A5 JP2011528665A5 JP2011518930A JP2011518930A JP2011528665A5 JP 2011528665 A5 JP2011528665 A5 JP 2011528665A5 JP 2011518930 A JP2011518930 A JP 2011518930A JP 2011518930 A JP2011518930 A JP 2011518930A JP 2011528665 A5 JP2011528665 A5 JP 2011528665A5
- Authority
- JP
- Japan
- Prior art keywords
- denv
- polypeptide
- composition
- xaa
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8194308P | 2008-07-18 | 2008-07-18 | |
| US61/081,943 | 2008-07-18 | ||
| PCT/US2009/050966 WO2010009380A2 (en) | 2008-07-18 | 2009-07-17 | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528665A JP2011528665A (ja) | 2011-11-24 |
| JP2011528665A5 true JP2011528665A5 (https=) | 2012-09-13 |
| JP5806112B2 JP5806112B2 (ja) | 2015-11-10 |
Family
ID=41551029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518930A Expired - Fee Related JP5806112B2 (ja) | 2008-07-18 | 2009-07-17 | デング出血熱およびデングショック症候群を含む免疫介在性デング熱感染症およびデング熱感染症の抗体依存性増強を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8815813B2 (https=) |
| EP (1) | EP2320924B1 (https=) |
| JP (1) | JP5806112B2 (https=) |
| CN (1) | CN102159231B (https=) |
| AU (2) | AU2009270805B2 (https=) |
| BR (1) | BRPI0915968B1 (https=) |
| CA (1) | CA2731218A1 (https=) |
| HR (1) | HRP20150620T1 (https=) |
| IL (1) | IL210717A (https=) |
| MX (1) | MX2011000647A (https=) |
| MY (1) | MY160699A (https=) |
| SG (1) | SG10201500597YA (https=) |
| WO (1) | WO2010009380A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005221187B2 (en) | 2004-03-10 | 2011-09-01 | Trinity Therapeutics, Inc. | Method for inhibiting immune complex formation in a subjetc |
| MX2011000647A (es) | 2008-07-18 | 2011-09-29 | Trinity Therapeutics Inc | Metodos para el tratamiento de infecciones por fiebre de dengue mediadas por el sistema inmunitario e intensificacion dependiente de anticuerpos de infecciones por fiebre de dengue, incluyendo fiebre hemorragica de dengue y sindrome de choque de deng |
| EP3236986A4 (en) * | 2014-12-22 | 2018-10-24 | Middle Tennessee State University | Methods for treating immune-mediated viral infections |
| ES3058443T3 (es) * | 2015-05-20 | 2026-03-10 | Univ Kagoshima | Modificación específica de anticuerpo con péptido de unión a IgG |
| WO2017189891A1 (en) * | 2016-04-27 | 2017-11-02 | Middle Tennessee State University | Methods for treating zika viral infections and associated complications |
| DK3470418T3 (da) | 2016-06-13 | 2024-09-30 | Univ Kagoshima | Site-specifik radioisotop-mærket antistof ved brug af using iggbindende peptid |
| CN115804362A (zh) * | 2023-02-08 | 2023-03-17 | 中国医学科学院医学生物学研究所 | 一种IFN-α/βR-/-小鼠抗体依赖性增强感染的注射液及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189014A (en) * | 1979-12-03 | 1993-02-23 | Cowan Jr Fred M | Method of treating cellular Fc receptor mediated hypersensitivity immune disorders |
| US4383317A (en) * | 1980-10-30 | 1983-05-10 | Bei Electronics, Inc. | Shaft angle encoder having a circuit for synthesizing a skipped track output signal |
| IT1190891B (it) | 1982-06-24 | 1988-02-24 | Anic Spa | Metodo per la sintesi in fase solida di polipeptidi retroinvertiti |
| US5693758A (en) * | 1987-11-19 | 1997-12-02 | 501 Research Corporation Limited | Immunoglobulin E competitor |
| US5932483A (en) * | 1990-10-16 | 1999-08-03 | Northwestern University | Synthetic peptide and its uses |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US6420127B1 (en) * | 1994-11-18 | 2002-07-16 | Washington University | Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| US6319897B1 (en) * | 1996-03-13 | 2001-11-20 | John D. Lambris | Peptides which inhibit complement activation |
| ITMI962628A1 (it) | 1996-12-16 | 1998-06-16 | Tecnogen Scpa | Composizione farmaceutica |
| WO2000015214A1 (en) * | 1998-09-11 | 2000-03-23 | Ilexus Pty Limited | Fc RECEPTOR MODULATORS AND USES THEREOF |
| US6818611B1 (en) * | 1998-10-13 | 2004-11-16 | University Of Georgia Research Foundation, Inc. | Stabilized bioactive peptides and methods of identification, synthesis and use |
| US20030190740A1 (en) | 1998-10-13 | 2003-10-09 | The University Of Georgia Research Foundation, Inc | Stabilized bioactive peptides and methods of identification, synthesis, and use |
| EP1240337B1 (en) | 1999-12-24 | 2006-08-23 | Genentech, Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
| WO2002038592A2 (de) | 2000-11-08 | 2002-05-16 | Affina Immuntechnik Gmbh | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen |
| US6916904B2 (en) | 2002-04-24 | 2005-07-12 | Zolaris Biosciences, Llc | Inhibition of immune complex formation |
| DE60318065T2 (de) | 2002-06-07 | 2008-11-20 | Trillium Therapeutics Inc., Toronto | Fcyriia-transgenes tiermodell für autoimmunkrankheit |
| AU2002953533A0 (en) | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
| AU2005221187B2 (en) * | 2004-03-10 | 2011-09-01 | Trinity Therapeutics, Inc. | Method for inhibiting immune complex formation in a subjetc |
| ES2388501T3 (es) | 2004-08-12 | 2012-10-16 | Helsinn Healthcare S.A. | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal |
| CN101277714B (zh) * | 2005-09-06 | 2013-01-30 | 三一治疗公司 | 治疗免疫介导的神经疾病的方法 |
| EP1960427B1 (en) | 2005-12-13 | 2011-02-23 | SuppreMol GmbH | Multimeric fc receptor polypeptides |
| US20120021988A1 (en) * | 2007-08-14 | 2012-01-26 | Bodie Neil M | Methods for treating immune thrombocytopenia |
| MX2011000647A (es) | 2008-07-18 | 2011-09-29 | Trinity Therapeutics Inc | Metodos para el tratamiento de infecciones por fiebre de dengue mediadas por el sistema inmunitario e intensificacion dependiente de anticuerpos de infecciones por fiebre de dengue, incluyendo fiebre hemorragica de dengue y sindrome de choque de deng |
-
2009
- 2009-07-17 MX MX2011000647A patent/MX2011000647A/es active IP Right Grant
- 2009-07-17 WO PCT/US2009/050966 patent/WO2010009380A2/en not_active Ceased
- 2009-07-17 SG SG10201500597YA patent/SG10201500597YA/en unknown
- 2009-07-17 US US13/054,738 patent/US8815813B2/en not_active Expired - Fee Related
- 2009-07-17 CA CA2731218A patent/CA2731218A1/en not_active Abandoned
- 2009-07-17 HR HRP20150620TT patent/HRP20150620T1/hr unknown
- 2009-07-17 JP JP2011518930A patent/JP5806112B2/ja not_active Expired - Fee Related
- 2009-07-17 MY MYPI2011000225A patent/MY160699A/en unknown
- 2009-07-17 CN CN200980136119.9A patent/CN102159231B/zh not_active Expired - Fee Related
- 2009-07-17 BR BRPI0915968-1A patent/BRPI0915968B1/pt not_active IP Right Cessation
- 2009-07-17 EP EP09798797.8A patent/EP2320924B1/en active Active
- 2009-07-17 AU AU2009270805A patent/AU2009270805B2/en not_active Ceased
-
2011
- 2011-01-18 IL IL210717A patent/IL210717A/en active IP Right Grant
-
2017
- 2017-02-03 AU AU2017200760A patent/AU2017200760A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528665A5 (https=) | ||
| JP2020178703A5 (https=) | ||
| JP2006149395A5 (https=) | ||
| JP2020534828A5 (https=) | ||
| JP2006523711A5 (https=) | ||
| JP2015134758A5 (https=) | ||
| JP2007513634A5 (https=) | ||
| JP2014506790A5 (https=) | ||
| JP2015533490A5 (https=) | ||
| JP2011087580A5 (https=) | ||
| JP2009268467A5 (https=) | ||
| IL199263A (en) | Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation | |
| JP2007529204A5 (https=) | ||
| JP2019500414A5 (https=) | ||
| JP2003530124A5 (https=) | ||
| JP2005511038A5 (https=) | ||
| JP2006503088A5 (https=) | ||
| JP2008517998A5 (https=) | ||
| WO2009153518A3 (fr) | Nouvelles proteines de fusion et leur application pour la preparation de vaccins contre l'hepatite c | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| JP2004532037A5 (https=) | ||
| WO2008142664A3 (en) | Exposed thymidine kinase 1 peptides, ligands and methods employing the same | |
| JP2007536910A5 (https=) | ||
| JP2005509160A5 (https=) | ||
| WO2005042717A3 (en) | Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |